Pharmafile Logo

5 takeaways from Reuters’ Pharma USA 2026 – and what they mean for you

April 15, 2026 |  

Pharma USA is North America’s largest cross-functional pharma event and Inizio was there to offer insights on patient engagement, accelerated product launches, and Intelligent Commercialization™. Now we’re back in the office, it’s time to share our thoughts on some of the key themes discussed in Philadelphia.

- PMLiVE

More than a dozen colleagues from Inizio IgniteInizio Engage, and Inizio Evoke attended Pharma USA 2026 in mid-March. While we were there, we ran a workshop on designing insight-driven patient support, and hosted a live session on the practical strategies pharma teams can employ to drive focus, alignment, and smarter product launch execution.

These types of events are an excellent way to take the pulse of pharma and, with more than 170 speakers and 20 interactive sessions, Pharma USA was once again a hive of interesting ideas and hot topics.

1. AI is everywhere – but the real differentiator is the quality of the data behind it.

It’s no surprise that conversations about AI were happening everywhere at Pharma USA, but one of the more interesting takes wasn’t about the amazing things the technology can do, but how quality data is fundamental to its successful implementation.

What became clear in conversations across the event is that while many organizations are investing heavily in AI, those seeing real impact are the ones grounding it in well-structured, proprietary data and embedding it into real decision-making workflows.

In a landscape where teams are already navigating increasing complexity, more stakeholders, and compressed timelines, simply adding more data or tools does not guarantee better outcomes. The real question is whether those inputs are improving decision quality and enabling action at speed.

Read the full article here. 

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Research Partnership and Janssen awarded runner-up in MR Excellence Awards

We are delighted to announce that an entry by Janssen and Research Partnership for the 2019 EphMRA MR Excellence Awards has been awarded runner-up in the ‘Business Impact through Innovation’...

Infographic: The vaccine opportunity in Asia

Asia is home to 60% of the world’s population and is one of the fastest growing vaccine markets in the world. A rising demand for better healthcare infrastructure and high...

Event: World Pharma Pricing and Market Access Congress

Directors Brett Gardiner and Rachel Howard attended the World Pharma Pricing and Market Access Congress in Amsterdam in March.This two-day event was attended by over 600 delegates, including a number...

Event: Intellus Worldwide Summit 2019

Visit us on stand number 311

Blog: The Future of Food Allergy? The Emergence of Targeted Allergy Treatments

Research Analyst Rachel Arthurs explores how public exposure to the complications of food allergy has affected attitudes toward treatment.In recent years, there has been a noticeable shift in the increased...

News: Research Partnership is listed in the Alantra Pharma Fast 50 annual report

The best performing privately-owned UK pharmaceutical businesses were revealed earlier this month with the publication of Pharma Times’ Alantra Pharma Fast 50 annual report.Read more about this report here

Event: Blending data science and market research at the Data Analytics & Insight conference

Last month Analytics Director Misti Paul attended the Data Analytics & Insight Conference. In our latest blog post she reflects on the presentations that were given and what lessons can be...

Presentation: Optimize your digital assets with UX research

US Director Liza Pliss recently presented the paper 'Optimize your digital assets with UX research' at the PMR Conference in New Jersey, USA. Don't worry if you missed it though,...

Report: Living With Rheumatoid Arthritis 2019 reports now available to purchase

We have published new Living with Rheumatoid Arthritis reports in 5EU, Japan and Canada. The reports consist of 30-minute quantitative online and qualitative telephone interviews with RA patients. Read more on...

Infographic: Rheumatoid arthritis (RA)

An overview of the RA biologic patientOur RA market snapshot offers an introduction to the real world patient data collected by our Therapy Watch RA study. The snapshot looks at...